Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial. uri icon

Overview

authors

publication date

  • December 1, 2024

Identity

Scopus Document Identifier

  • 85209061003

Digital Object Identifier (DOI)

  • 10.1038/s41591-024-03404-w

PubMed ID

  • 39548313

Additional Document Info

volume

  • 30

issue

  • 12